Publikationen von Madhu Emmadi

Kaplonek, P.; Yao, L.; Reppe, K.; Voß, F.; Kohler, T.; Ebner, F.; Schäfer, A.; Blohm, U.; Priegue, P.; Bräutigam, M. et al.; Pereira, C. L.; Parameswarappa, S. G.; Emmadi, M.; Ménová, P.; Witzenrath, M.; Hammerschmidt, S.; Hartmann, S.; Sander, L. E.; Seeberger, P. H.: A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine (2022)

Kaplonek, P.; Khan, N.; Reppe, K.; Schumann, B.; Emmadi, M.; Lisboa, M. P.; Xu, F.-F.; Calow, A. D. J.; Parameswarappa, S. G.; Witzenrath, M. et al.; Pereira, C. L.; Seeberger, P. H.: Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proceedings of the National Academy of Sciences of the United States of America 115 (52), S. 13353 - 13358 (2018)

Emmadi, M.; Khan, N.; Lykke, L.; Reppe, K.; Parameswarappa, S.; Lisboa, M. P.; Wienhold, S.-M.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Journal of the American Chemical Society 139 (41), S. 14783 - 14791 (2017)

Khan, N.; Emmadi, M.: Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)